1. Latest News
  2. Submit Press Release
Journal of Commercial Biotechnology Logo

Journal of Commercial Biotechnology: January 2012 issue now available

The January 2012 issue of the Journal of Commercial Biotechnology is now available. Contents include Original Articles, From the Boardroom, From the Classroom, Legal and Regulatory Update, and Book Reviews

Dec. 28, 2011 - PRLog -- Journal of Commercial Biotechnology Vol 18, Issue 1 (2012)

Exciting changes    
Yali Friedman    

Bacterial proteins: A new class of cancer therapeutics    
Ananda Mohan Chakrabarty    
Industrial biotechnology – Markets and industry structure    
Gunter Festel, Christian Detzel, Ruth Maas    
Options to Change Medicare Payment for Outpatient Prescription Drugs and Biotechnology Products    
Thomas Barker, Maia Larsson    
The Emergence of Bio-Clusters in Egypt and South Africa    
Ramazan Uctu, Nirvana Shanalee Pillay    
Patent litigation in India and interim injunctions — An evolving jurisprudence    
Rajashree Sharma, Dinesh Kumar Sharma    

Digital health investment opportunities abound, but standouts deliver disruptive change    
G. Steven Burrill    
Strategies for Collaboration Agreements Focusing on Innovation    
Pamela Cox    
Biomarketing strategy and tactics 101 PART I of III    
Dimitris Dogramatzis    

The University of Colorado Certificate Program in Bioinnovation and Entrepreneurship: An Interdisciplinary, Cross-Campus Model    PDF Restricted Access
Madhavan Parthasarathy, David Forlani, Arlen Meyers    

EU Legal & Regulatory Update    
Ewan Grist    
Post-Grant Review: The Good, the Bad and the Ugly for Biotechnology Companies    
Smitha Uthaman, Deborah Lu, Thomas Kowalski    

Book Review: Constructing and Deconstructing Patents by Irah H. Donner    
David B. Orange    
Book Review: Plunkett’s Biotech & Genetics Industry Almanac 2012    
Barry J. Marenberg

For more, see the Journal of Commercial Biotechnology at http://CommercialBiotechnology.com

# # #

The Journal of Commercial Biotechnology is a quarterly peer-reviewed professional journal which focuses on the commercial, legal, and regulatory issues affecting biotechnology, biopharmaceutical, agrochemical, and environmental companies.

--- End ---

Click to Share

Contact Email:
***@commercialbiotechnology.com Email Verified
Source:Yali Friedman, Ph.D.
Location:Washington - District of Columbia - United States
Industry:Biotech, Business, Medical
Tags:Biotechnology, Business, Journal, Commercial, Policy, Law, Legal, Regulatory
Verified Account Email Address
Verified Account Phone Number

Disclaimer:   Issuers of the press releases are solely responsible for the content of their press releases. PRLog can't be held liable for the content posted by others.   Report Abuse

Latest Press Releases By “


Trending News...

Like PRLog?
Click to Share